Bangkok Genomics Innovation Public Company Limited(TH:BKGI)
฿2.100.00 (0.00%)
TH:BKGI
Bangkok Genomics Innovation Public Company Limited financials statements
฿2.10
At close:0.00 (0.00%)
Bangkok Genomics Innovation Public Company Limited (BKGI) Financial Statements
Bangkok Genomics Innovation Public Company Limited Financial Overview
Bangkok Genomics Innovation Public Company Limited's market cap is currently ฿1.26B. The company's EPS TTM is ฿0.16; its P/E ratio is 11.19; and it has a dividend yield of 2.38%. Bangkok Genomics Innovation Public Company Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ฿ 379.51M | ฿ 337.59M | ฿ 245.39M | ฿ 304.77M | ฿ 379.31M |
| Gross Profit | ฿ 150.04M | ฿ 140.08M | ฿ 116.10M | ฿ 153.89M | ฿ 165.03M |
| Operating Income | ฿ 42.40M | ฿ 53.85M | ฿ 32.84M | ฿ 64.44M | ฿ 105.91M |
| EBITDA | ฿ 63.95M | ฿ 70.17M | ฿ 49.55M | ฿ 94.27M | ฿ 115.13M |
| Net Income | ฿ 45.35M | ฿ 50.17M | ฿ 32.14M | ฿ 75.11M | ฿ 105.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ฿ 221.74M | ฿ 389.93M | ฿ 165.90M | ฿ 148.34M | ฿ 50.65M |
| Total Assets | ฿ 701.86M | ฿ 607.60M | ฿ 293.02M | ฿ 300.58M | ฿ 187.74M |
| Total Debt | ฿ 21.47M | ฿ 24.00M | ฿ 23.72M | ฿ 31.63M | ฿ 10.65M |
| Net Debt | ฿ -200.27M | ฿ -365.93M | ฿ -102.17M | ฿ -116.72M | ฿ -40.01M |
| Total Liabilities | ฿ 148.70M | ฿ 68.44M | ฿ 57.20M | ฿ 52.90M | ฿ 38.48M |
| Stockholders' Equity | ฿ 551.23M | ฿ 537.20M | ฿ 235.82M | ฿ 247.68M | ฿ 149.25M |
| Cash Flow | |||||
| Free Cash Flow | ฿ -124.43M | ฿ -23.46M | ฿ 66.76M | ฿ 53.00M | ฿ 42.15M |
| Operating Cash Flow | ฿ -88.16M | ฿ -3.50M | ฿ 71.85M | ฿ 81.18M | ฿ 55.64M |
| Investing Cash Flow | ฿ 44.23M | ฿ -169.90M | ฿ -44.55M | ฿ -1.50M | ฿ -13.49M |
| Financing Cash Flow | ฿ -33.86M | ฿ 247.56M | ฿ -49.66M | ฿ 18.06M | ฿ -3.25M |
Currency in THB
